79 related articles for article (PubMed ID: 26968716)
1. Predictors of survival for patients with cancer after cryptogenic stroke.
Shin YW; Lee ST; Jung KH; Kim DY; Park CK; Kim TM; Choi SH; Chu K; Lee SK
J Neurooncol; 2016 Jun; 128(2):277-84. PubMed ID: 26968716
[TBL] [Abstract][Full Text] [Related]
2. Tumor metastasis has a significant relationship with the development of acute ischemic stroke in Chinese cancer patients: a retrospective study.
Wu S; Xing Z; Lin J; Cui F; Liu H
J Int Med Res; 2021 Jan; 49(1):300060520986298. PubMed ID: 33478293
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and prognostic factors of patients with cancer-associated stroke.
Sawada J; Katayama T; Kikuchi-Takeguchi S; Kano K; Saito M; Mitsui N; Hiroshima S; Kinoshita M; Nakagawa N
Neurol Sci; 2024 Jun; 45(6):2747-2757. PubMed ID: 38267601
[TBL] [Abstract][Full Text] [Related]
4. D-Dimer Trends Predict Recurrent Stroke in Patients with Cancer-Related Hypercoagulability.
Fujinami J; Nagakane Y; Fujikawa K; Murata S; Maezono K; Ohara T; Mizuno T
Cerebrovasc Dis Extra; 2024; 14(1):9-15. PubMed ID: 38061347
[TBL] [Abstract][Full Text] [Related]
5. Cancer patients and ischemic stroke.
Kawano T; Mackman N
Thromb Res; 2024 May; 237():155-162. PubMed ID: 38603819
[TBL] [Abstract][Full Text] [Related]
6. D-dimer as a predictor of early neurologic deterioration in cryptogenic stroke with active cancer.
Nam KW; Kim CK; Kim TJ; An SJ; Demchuk AM; Kim Y; Jung S; Han MK; Ko SB; Yoon BW
Eur J Neurol; 2017 Jan; 24(1):205-211. PubMed ID: 27766716
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of cryptogenic stroke in cancer patients.
Gon Y; Okazaki S; Terasaki Y; Sasaki T; Yoshimine T; Sakaguchi M; Mochizuki H
Ann Clin Transl Neurol; 2016 Apr; 3(4):280-7. PubMed ID: 27081658
[TBL] [Abstract][Full Text] [Related]
8. Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study.
Lee MJ; Chung JW; Ahn MJ; Kim S; Seok JM; Jang HM; Kim GM; Chung CS; Lee KH; Bang OY
J Stroke; 2017 Jan; 19(1):77-87. PubMed ID: 28030894
[TBL] [Abstract][Full Text] [Related]
9. Plasma D-dimer levels and ischaemic lesions in multiple vascular regions can predict occult cancer in patients with cryptogenic stroke.
Gon Y; Sakaguchi M; Takasugi J; Kawano T; Kanki H; Watanabe A; Oyama N; Terasaki Y; Sasaki T; Mochizuki H
Eur J Neurol; 2017 Mar; 24(3):503-508. PubMed ID: 28026909
[TBL] [Abstract][Full Text] [Related]
10. Ischemic stroke: A paradoxical manifestation of cancer.
Salazar-Camelo RA; Moreno-Vargas EA; Cardona AF; Bayona-Ortiz HF
Crit Rev Oncol Hematol; 2021 Jan; 157():103181. PubMed ID: 33264715
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Survival in Patients With Ischemic Stroke and Active Cancer: A Prospective, Multicenter, Observational Study.
Gon Y; Sakaguchi M; Yamagami H; Abe S; Hashimoto H; Ohara N; Takahashi D; Abe Y; Takahashi T; Kitano T; Okazaki S; Todo K; Sasaki T; Hattori S; Mochizuki H;
J Am Heart Assoc; 2023 Aug; 12(15):e029618. PubMed ID: 37489755
[TBL] [Abstract][Full Text] [Related]
12. Clinical and Demographic Characteristics, Mechanisms, and Outcomes in Patients With Acute Ischemic Stroke and Newly Diagnosed or Known Active Cancer.
Costamagna G; Hottinger A; Milionis H; Lambrou D; Salerno A; Strambo D; Livio F; Navi BB; Michel P
Neurology; 2023 Jun; 100(24):e2477-e2489. PubMed ID: 37094994
[TBL] [Abstract][Full Text] [Related]
13. Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomes.
Navi BB; Zhang C; Sherman CP; Genova R; LeMoss NM; Kamel H; Tagawa ST; Saxena A; Ocean AJ; Kasner SE; Cushman M; Elkind MSV; Peerschke E; DeAngelis LM
J Thromb Haemost; 2022 Sep; 20(9):2046-2057. PubMed ID: 35652416
[TBL] [Abstract][Full Text] [Related]
14. Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer.
Nam KW; Kwon HM; Lee YS
PLoS One; 2021; 16(11):e0259627. PubMed ID: 34739530
[TBL] [Abstract][Full Text] [Related]
15. Effects of cerebral small vessel disease on the outcomes in cryptogenic stroke with active cancer.
Nam KW; Kwon HM; Lee YS; Kim JM; Ko SB
Sci Rep; 2021 Sep; 11(1):17510. PubMed ID: 34471193
[TBL] [Abstract][Full Text] [Related]
16. A Systematic Review of the Predictive Value of Plasma D-Dimer Levels for Predicting Stroke Outcome.
Zhang P; Wang C; Wu J; Zhang S
Front Neurol; 2021; 12():693524. PubMed ID: 34295302
[No Abstract] [Full Text] [Related]
17. Cancer and Embolic Stroke of Undetermined Source.
Navi BB; Kasner SE; Elkind MSV; Cushman M; Bang OY; DeAngelis LM
Stroke; 2021 Mar; 52(3):1121-1130. PubMed ID: 33504187
[TBL] [Abstract][Full Text] [Related]
18. It's Time to Say Goodbye to the ESUS Construct.
Fuentes B; Gutiérrez-Zúñiga R; Díez-Tejedor E
Front Neurol; 2020; 11():653. PubMed ID: 32733368
[No Abstract] [Full Text] [Related]
19. Cancer-Related Stroke: An Emerging Subtype of Ischemic Stroke with Unique Pathomechanisms.
Bang OY; Chung JW; Lee MJ; Seo WK; Kim GM; Ahn MJ;
J Stroke; 2020 Jan; 22(1):1-10. PubMed ID: 32027788
[TBL] [Abstract][Full Text] [Related]
20. Cancer and Cerebrovascular Disease.
Adams HP
Curr Neurol Neurosci Rep; 2019 Aug; 19(10):73. PubMed ID: 31440841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
